Uptake of Trastuzumab Biosimilars for the Treatment of HER2-Positive Breast Cancer: A Real-World Experience from a Cancer Center

• Main Authors: Michela Piezzo (Author), Roberta D'Aniello (Author), Ilaria Avallone (Author), Bruno Barba (Author), Daniela Cianniello (Author), Stefania Cocco (Author), Antonio D'Avino (Author), Germira Di Gioia (Author), Vincenzo Di Lauro (Author), Giuseppina Fusco (Author), Raffaele Piscitelli (Author), Claudia von Arx (Author), Michelino De Laurentiis (Author), Piera Maiolino (Author)
• Format: Book
• Published: MDPI AG, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The introduction of trastuzumab biosimilars in clinical practice plays an important role in promoting the sustainability of healthcare systems. By contrast, the switching process can be challenging to the clinics. This survey describes the switching process at a National Cancer Institute...